A--Gene Therapy Resource Program (GTRP)

A--Gene Therapy Resource Program (GTRP)(Expired)

Dates

Bid Notification started - 06 Dec, 2017 (11 months ago) - A--Gene Therapy Resource Program (GTRP)

Start Date

06 Dec, 2017 (11 months ago)
Bid Notification due - 06 Dec, 2017 (11 months ago) - A--Gene Therapy Resource Program (GTRP)

Due Date

09 Jan, 2018 (10 months ago)
Bid Notification - A--Gene Therapy Resource Program (GTRP)

Opportunity Type

Bid Notification
HHSN26818HV00005R - A--Gene Therapy Resource Program (GTRP)

Opportunity Identifier

HHSN26818HV00005R
Bid Notification Department of Health and Human Services - A--Gene Therapy Resource Program (GTRP)

Customer / Agency

Department of Health and Human Services
Bid Notification National Institutes of Health National Heart, Lung, and Blood Institutes Bethesda MD 20892-7511 - A--Gene Therapy Resource Program (GTRP)

Location

National Institutes of Health National Heart, Lung, and Blood Institutes Bethesda MD 20892-7511
From: Federal Government(Federal)
Added:
Sep 19, 2017 3:45 pm
Modified:
Oct 04, 2017 5:03 pm
Track Changes The NHLBI requires the Gene Therapy Resource Program (GTRP) support translational gene therapy research by providing resources and services from four core laboratories: 1.) Pharmacology and Toxicology Core Laboratory, 2.) Preclinical Vector Core Laboratory, 3.) a Good Manufacturing Practices (GMP)-grade Adeno-Associated Virus (AAV) Vector Core Laboratory, and 4.) GMP-grade Lentivirus Vector Core Laboratory. Additionally, the overall orchestration of the program is to be handled by a Clinical Coordinating Center (CCC), which is not required to have any laboratory capabilities.

Added:
Sep 19, 2017 3:45 pm
Modified:
Dec 06, 2017 10:27 am
Track Changes The NHLBI requires the Gene Therapy Resource Program (GTRP) support translational gene therapy research by providing resources and services from four core laboratories: 1.) Pharmacology and Toxicology Core Laboratory, 2.) Preclinical Vector Core Laboratory, 3.) a Good Manufacturing Practices (GMP)-grade Adeno-Associated Virus (AAV) Vector Core Laboratory, and 4.) GMP-grade Lentivirus Vector Core Laboratory. Additionally, the overall orchestration of the program is to be handled by a Clinical Coordinating Center (CCC), which is not required to have any laboratory capabilities.

Added:
Nov 17, 2017 12:57 pm Amendment One (1)
Attachments (1)
Amendment_One_(1)_.pdf

Location

Country : United States

State : Maryland